From USFDA
Lupin announced that it has received final approval for its Omeprazole Delayed-Release capsules 40 mg from the United States Food and Drugs Adminstration (FDA) to market a generic version of AstraZeneca Pharmaceuticals LP Prilosec Delayed-Release capsules 40 mg. It is indicated for the short term treatment of Duodenal Ulcer, Gastric Ulcer, treatment of Gastro Esophageal Reflux Disease (GERD), maintenance of healing of Erosive Esophagitis and Pathological Hypersecretory conditions.Powered by Capital Market - Live News